CTA
ARNA

Carillon Tower Advisers’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Carillon Tower Advisers’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-408,504
Closed -$30.6M – 499
2020
Q3 		$30.6M Sell
408,504
-145,987
-26% -$9.73M 0.41% 68
2020
Q2 		$34.9M Sell
554,491
-111,092
-17% -$6.11M 0.27% 120
2020
Q1 		$27.1M Hold
665,583
– – 0.27% 131
2019
Q4 		$30.2M Hold
665,583
– – 0.2% 178
2019
Q3 		$30.5M Hold
665,583
– – 0.21% 159
2019
Q2 		$39M Hold
665,583
– – 0.27% 130
2019
Q1 		$29.8M Buy
+665,583
New +$30.5M 0.21% 178

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Carillon Tower Advisers's ARNA Position: Q4 2020 in Review

Carillon Tower Advisers sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2020, closing a stake of 408,504 shares — an estimated $30.6M sold.

Carillon Tower Advisers first reported a position in ARNA in Q1 2019 and held it in 7 quarters. The position peaked at $39M in Q2 2019. 254 funds tracked by Wall St. Rank hold ARNA as of Q4 2020.

  • Carillon Tower Advisers reported no remaining Arena Pharmaceuticals Inc position as of Q4 2020 after selling out during the quarter.
  • Carillon Tower Advisers sold 408,504 Arena Pharmaceuticals Inc shares in Q4 2020, an estimated $30.6M.
  • Carillon Tower Advisers first reported a position in Arena Pharmaceuticals Inc in Q1 2019 and held it in 7 quarters.
  • Carillon Tower Advisers's Arena Pharmaceuticals Inc position peaked at $39M in Q2 2019.
  • 254 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.